Why the study?
ACS remains a leading cause of cardiovascular morbidity and mortality, requiring timely identification, risk stratification, and intervention in patients presenting with chest pain.
This review highlights the 20-year evolution and future directions of an institutional chest pain clinical pathway for timely identification and risk stratification of acute coronary syndromes.
Answers are grounded in this paper and cite their sources.
Periodic updates to chest pain pathways may aid ACS risk stratification; leaves open prospective validation of emerging tools.
Acute coronary syndromes (ACS) remain one of the leading causes of cardiovascular morbidity and mortality in the United States and around the world. Because of the acute nature of ACS presentations, timely identification, risk stratification, and intervention are of the utmost importance. Twenty years ago, we published the first iteration of our institutional chest pain clinical pathway in this journal, which separated patients presenting with chest pain into one of the 4 levels of decreasing acuity, with associated actions and interventions for providers based on the level. This chest pain clinical pathway has undergone regular review and updates under a collaborative team of cardiologists, emergency department physicians, cardiac nurse practitioners, and other associated stakeholders in the treatment of patients presenting with chest pain. This review will discuss the key changes that our institutional chest pain algorithm has undergone over the last 2 decades and what the future holds for chest pain algorithms.
No takes yet. Share an insight, caveat, or question.
Zilinyi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: